MET and prostate carcinoma: Moreover, studies have shown that HGF/c-Met can regulate the YAP pathway thereby promoting proliferation and migration of tumor cells leading to stemness maintenance of CSLCs in hepatocellular carcinoma and prostate cancer [27, 28].